Skip to main content
OpenTrials
Completed

NCT Number: NCT06146179

Combined Anterior Suprascapular Nerve Block and Superficial Cervical Plexus Block In Shoulder Arthroplasty Surgery

The suprascapular nerve, originating from the C5 trunk, provides innervation to the acromioclavicular and glenohumeral joints. The supraclavicular nerve, a branch of the cervical plexus, contributes to the sensory innervation of the upper deltoid region. Cervical and brachial plexus blocks can cause diaphragm paralysis. This study examined the effects of low-volume combined anterior suprascapular nerve block and superficial cervical plexus block on pain and phrenic nerve in participants underwent reverse shoulder arthroplasty surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diaphragmatic Paralysis Anterior Suprascapular Nerve Block Arthralgia Joint Diseases Musculoskeletal Diseases Nervous System Diseases Neurologic Manifestations Pain Paralysis Pathological Conditions, Signs and Symptoms Phrenic Nerve Paralysis Respiration Disorders Respiratory Insufficiency Respiratory Paralysis Respiratory Tract Diseases Shoulder Pain Signs and Symptoms Superficial Cervical Plexus Block

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Medeniyet University

Istanbul, 34722, Turkey (Türkiye)

About this study

A retrospective analysis was performed on data obtained from eight participants who underwent reverse shoulder arthroplasty surgery. Anterior suprascapular nerve block and superficial cervical plexus block were applied to these participants. Anterior suprascapular nerve block was performed using 5 ml and superficial cervical plexus block was performed using 3 ml of %0,5 bupivacaine. Ultrasound was used to measure the diaphragm thickness at the end of inspiration and expiration, and to calculate the diaphragm thickness fraction. Postoperative pain management included patient-controlled analgesia with morphine, opioid consumption and VAS score recorded by pain observation forms.

Data will be collected by examining these pain observation forms and diaphragm thickness measurements.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Population is defined by database within a given time frame
  • Participants who underwent combined anterior suprascapular nerve block and superficial cervical plexus block in reverse shoulder arthroplasty surgery
  • Participants aged 18-80
  • ASA I-II-III

Exclusion criteria

  • ASA score > III
  • Pediatric individuals under 18 years of age
  • Individuals who are pregnant
  • Known diaphragmatic paralysis
  • Had an allergy or toxicity to local anesthetic agents
  • Have an opioid drug allergy

Treatment and study plan

Primary outcomes

  1. Postoperative Change Ratio of Diaphragm Thickness Fraction

    Time frame: Postoperatively 30th. min.

    Postoperative Change Ratio of Diaphragm Thickness Fraction (%) at Postoperatively 30th. min.

Secondary outcomes

  1. Pain Assessment with Visual Analogue Scale at postoperatively 30th. Min.

    Time frame: Postoperatively 30th. min

    Postoperative VAS score (Ranging from 0-10)

  2. Pain Assessment with Visual Analogue Scale at postoperatively 4th. Hours.

    Time frame: Postoperatively 4th. hour

    Postoperative VAS score (Ranging from 0-10)

  3. Pain Assessment with Visual Analogue Scale at postoperatively 6th. Hours.

    Time frame: Postoperatively 6th. hour

    Postoperative VAS score (Ranging from 0-10)

  4. Pain Assessment with Visual Analogue Scale at postoperatively 12th. Hours.

    Time frame: Postoperatively 12th. hour

    Postoperative VAS score (Ranging from 0-10)

  5. Pain Assessment with Visual Analogue Scale at postoperatively 24th. Hours.

    Time frame: Postoperatively 24th. hour

    Postoperative VAS score (Ranging from 0-10)

  6. Opioid Consumption at postoperatively 30th. Min.

    Time frame: Postoperatively 30th. min.

    Postoperative Opioid Consumption with Morphine PCA (0.5 mg/cc, demand dose 2 cc, lock of time; 10 min. )

  7. Opioid Consumption at postoperatively 4th. Hours.

    Time frame: Postoperatively 4th. hour

    Postoperative Opioid Consumption with Morphine PCA (0.5 mg/cc, demand dose 2 cc, lock of time; 10 min. )

  8. Opioid Consumption at postoperatively 6th. Hours.

    Time frame: Postoperatively 6th. hour

    Postoperative Opioid Consumption with Morphine PCA (0.5 mg/cc, demand dose 2 cc, lock of time; 10 min. )

  9. Opioid Consumption at postoperatively 12th. Hours.

    Time frame: Postoperatively 12th. hour

    Postoperative Opioid Consumption with Morphine PCA (0.5 mg/cc, demand dose 2 cc, lock of time; 10 min. )

  10. Opioid Consumption at postoperatively 24th. Hours.

    Time frame: Postoperatively 24th. hour

    Postoperative Opioid Consumption with Morphine PCA (0.5 mg/cc, demand dose 2 cc, lock of time; 10 min. )

Other outcomes

  1. Patient Satisfaction with 5 point Likert Patient Satisfaction scale at postoperatively 24th. Hours

    Time frame: Postoperatively 24th hour

    Postoperative 24th. hour 5 point Likert Patient Satisfaction scale (1-Very dissatisfied, 2 - Dissatisfied, 3 - Unsure, 4 - Satisfied, 5 - Very satisfied)

  2. Postoperative Nausea and Vomiting

    Time frame: During Postoperatively 24 hour

    Postoperative Nausea and Vomiting Score ( PONV0: No Nausea, No vomiting; PONV1: Nausea present, No vomiting; PONV2: Nausea and vomiting present; PONV3: Vomiting>2 epizodes in 30th. min; PONV4:Vomiting>3 epizodes in 30th.min)

Sponsors and collaborators

Lead sponsor

Istanbul Medeniyet University

Other

Registry information

Official study title

Application Of Combined Anterior Suprascapular Nerve Block and Superficial Cervical Plexus Block In Reverse Shoulder Arthroplasty Surgery, A Case Series

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 24, 2023
Registry last updated
Dec 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.